ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028

$1500$2200

This report infers that the Asia-Pacific epilepsy devices market is expected to showcase a CAGR of 8.38% during the forecast years 2022-2028.

SKU: TR-283-2022 Category: Tag:

Description

ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028

MARKET OUTLOOK

This report infers that the Asia-Pacific epilepsy devices market is expected to showcase a CAGR of 8.38% during the forecast years 2022-2028. Japan, China, India, ASEAN countries, Australia & New Zealand, South Korea, and Rest of Asia-Pacific are examined in the given region.
Japan provides a low-cost national health insurance system that is available to everyone. In this regard, several large hospitals offer a full range of medical services. Epilepsy procedures are undertaken in high volume owing to the robust local epileptic network. Considering these factors, epilepsy services are in high demand. And this trend is expected to remain over the forecast period due to a rise in patient visits to hospitals, clinics, and care facilities.
In South Korea, there is a high prevalence of epilepsy among the older population. Moreover, the rise in chronic CNS diseases is expected to surge the number of patients diagnosed with epilepsy, creating a treatment gap. In this regard, the introduction of the health insurance review and assessment (HIRA) system helps easily access information about diagnoses and medical services. Besides, the system pays for medical expenses incurred during epilepsy treatment. Therefore, such steps by the government are likely to boost the epilepsy devices market.

COMPETITIVE OUTLOOK

The key companies in the epilepsy devices market consist of Cadwell Industries Inc, Medtronic Plc, Boston Scientific Corporation, Empatica Inc, Natus Medical Incorporated, and Neurosoft.

TABLE OF CONTENTS

1. ASIA-PACIFIC EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. ASIA-PACIFIC EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH KOREA
7.5. ASEAN COUNTRIES
7.6. AUSTRALIA & NEW ZEALAND
7.7. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 24: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: CHINA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: JAPAN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: INDIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: SOUTH KOREA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: ASEAN COUNTRIES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 44: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

Additional information

Publisher

Date Published

Pages

Format

Companies Mentioned

1. LIVANOVA PLC
2. NATUS MEDICAL INCORPORATED
3. CADWELL INDUSTRIES INC
4. NIHON KOHDEN CORPORATION
5. COMPUMEDICS LIMITED
6. MEDTRONIC PLC
7. BOSTON SCIENTIFIC CORPORATION
8. EMPATICA INC
9. KONINKLIJKE PHILIPS NV
10. NEUROPACE INC
11. DRÄGERWERK AG & CO KGAA
12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
13. NEUROSOFT

Reviews

There are no reviews yet.

Be the first to review “ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028”